D-0324-2021 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- April 14, 2021
- Initiation Date
- March 31, 2021
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 55620 bottles
Product Description
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Reason for Recall
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: RX1662, RX1663, RX1664 Exp. 11/2022